JPWO2022244815A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022244815A5 JPWO2022244815A5 JP2023522701A JP2023522701A JPWO2022244815A5 JP WO2022244815 A5 JPWO2022244815 A5 JP WO2022244815A5 JP 2023522701 A JP2023522701 A JP 2023522701A JP 2023522701 A JP2023522701 A JP 2023522701A JP WO2022244815 A5 JPWO2022244815 A5 JP WO2022244815A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- human papillomavirus
- sequence
- particle
- particle according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021084441 | 2021-05-19 | ||
| PCT/JP2022/020713 WO2022244815A1 (ja) | 2021-05-19 | 2022-05-18 | Ｈｐｖ感染症ワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022244815A1 JPWO2022244815A1 (https=) | 2022-11-24 |
| JPWO2022244815A5 true JPWO2022244815A5 (https=) | 2025-05-22 |
Family
ID=84141666
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023522701A Pending JPWO2022244815A1 (https=) | 2021-05-19 | 2022-05-18 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250352632A2 (https=) |
| EP (1) | EP4342993A4 (https=) |
| JP (1) | JPWO2022244815A1 (https=) |
| TW (1) | TW202307211A (https=) |
| WO (1) | WO2022244815A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4059515A4 (en) * | 2019-11-15 | 2024-02-14 | Daiichi Sankyo Company, Limited | Nucleic acid lipid particle vaccine encapsulating hpv mrna |
| WO2026056860A1 (zh) * | 2024-09-10 | 2026-03-19 | 北京剂泰生命科技有限公司 | 用于递送hpv核酸疫苗的脂质纳米颗粒 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111808084A (zh) * | 2008-11-10 | 2020-10-23 | 阿布特斯生物制药公司 | 用于递送治疗剂的新型脂质和组合物 |
| MX360449B (es) * | 2011-10-12 | 2018-11-01 | Univ Pennsylvania | Vacunas para el virus del papiloma humano y metodos para su uso. |
| AU2014248535B2 (en) | 2013-03-12 | 2017-03-30 | Inovio Pharmaceuticals, Inc. | Improved vaccines for human papilloma virus and methods for using the same |
| EP3388834B1 (en) * | 2013-03-15 | 2020-04-15 | Translate Bio, Inc. | Synergistic enhancement of the delivery of nucleic acids via blended formulations |
| TW201534578A (zh) * | 2013-07-08 | 2015-09-16 | Daiichi Sankyo Co Ltd | 新穎脂質 |
| US10821175B2 (en) * | 2014-02-25 | 2020-11-03 | Merck Sharp & Dohme Corp. | Lipid nanoparticle vaccine adjuvants and antigen delivery systems |
| US10125092B2 (en) * | 2014-09-05 | 2018-11-13 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| AU2016342376A1 (en) * | 2015-10-22 | 2018-06-07 | Modernatx, Inc. | Sexually transmitted disease vaccines |
| CN110402145A (zh) * | 2016-10-26 | 2019-11-01 | 莫得纳特斯公司 | 用于增强免疫应答的信使核糖核酸及其使用方法 |
| EP3655536A1 (en) * | 2017-07-17 | 2020-05-27 | GlaxoSmithKline Biologicals SA | Lyssavirus antigen constructs |
| JP7075130B2 (ja) * | 2019-10-25 | 2022-05-25 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | ヒトパピローマウイルスのワクチンおよびその使用方法 |
| EP4059515A4 (en) * | 2019-11-15 | 2024-02-14 | Daiichi Sankyo Company, Limited | Nucleic acid lipid particle vaccine encapsulating hpv mrna |
-
2022
- 2022-05-18 WO PCT/JP2022/020713 patent/WO2022244815A1/ja not_active Ceased
- 2022-05-18 US US18/561,804 patent/US20250352632A2/en active Pending
- 2022-05-18 TW TW111118509A patent/TW202307211A/zh unknown
- 2022-05-18 EP EP22804725.4A patent/EP4342993A4/en active Pending
- 2022-05-18 JP JP2023522701A patent/JPWO2022244815A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4800485B2 (ja) | ポリヌクレオチドベースのワクチンに対する免疫応答を増強するためのアジュバント組成物および方法 | |
| JP2021138741A (ja) | 適応免疫応答を誘導するためのヌクレオシド修飾ｒｎａ | |
| CN115697298A (zh) | 脂质纳米颗粒 | |
| CN116133640A (zh) | 脂质纳米颗粒 | |
| EP2755680B1 (en) | Particulate vaccine formulations | |
| JPWO2022244815A5 (https=) | ||
| US20230270850A1 (en) | Hpv vaccine | |
| JP2025098089A (ja) | ＨＰＶ ｍＲＮＡを封入した核酸脂質粒子ワクチン | |
| JP2025160111A (ja) | 抗原提示細胞を標的とする脂質組成物及びその使用 | |
| Ahmad et al. | Liposomes and niosomes for targeted drug and gene delivery systems | |
| JPWO2021251453A5 (https=) | ||
| WO2024140893A1 (zh) | 一种类固醇-阳离子脂质化合物及其应用 | |
| JPWO2022244825A5 (https=) | ||
| EP2059262B1 (en) | A dna vaccine for treating or preventing cervical cancer comprising a gene encoding hpv protein | |
| WO2024099391A1 (zh) | 脂质-带电分子偶联物、可吸入式脂质纳米颗粒及其制备方法和应用 | |
| US20230118665A1 (en) | Novel thermostable lipid nanoparticle and methods of use thereof | |
| CN120813372A (zh) | 针对冠状病毒的疫苗 | |
| CN118695850A (zh) | 通用流感疫苗及使用方法 | |
| WO2024153111A1 (en) | Lipid conjugates, lipid nanoparticles and methods thereof | |
| CN114933565A (zh) | 一种核碱基衍生物纳米粒及其组合物 | |
| EA047059B1 (ru) | Вакцина против hpv | |
| WO2025023311A1 (ja) | ワクチンに使用するための組成物 | |
| RU2024105919A (ru) | Композиции и способы снижения иммунной непереносимости и лечения аутоиммунных расстройств | |
| CN114591386A (zh) | 一种含尿苷衍生物的纳米粒、核酸纳米复合物及其制备方法和用途 | |
| CN114605338A (zh) | 一种含尿嘧啶衍生物的纳米粒、核酸纳米复合物及其制备方法和用途 |